News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
29,366 Results
Type
Article (1370)
Company Profile (5)
Press Release (27991)
Section
Business (14939)
Career Advice (68)
Deals (1944)
Drug Development (3278)
FDA (437)
Job Trends (575)
News (19534)
Policy (811)
Tag
Academia (32)
Accelerated approval (1)
Allergies (6)
Alliances (1015)
ALS (7)
Alzheimer's disease (53)
Antibody-drug conjugate (ADC) (7)
Approvals (469)
Artificial intelligence (7)
Autoimmune disease (6)
Automation (1)
Bankruptcy (2)
Best Places to Work (515)
BIOSECURE Act (1)
Biosimilars (2)
Biotechnology (4)
Bladder cancer (11)
Brain cancer (3)
Breast cancer (24)
Cancer (169)
Cardiovascular disease (20)
Career advice (63)
CAR-T (11)
CDC (1)
Cell therapy (17)
Cervical cancer (2)
Clinical research (2914)
Collaboration (18)
Compensation (22)
Complete response letters (1)
COVID-19 (75)
CRISPR (7)
C-suite (7)
Cystic fibrosis (7)
Data (262)
Depression (5)
Diabetes (21)
Diagnostics (223)
Digital health (1)
Diversity (1)
Drug discovery (3)
Drug pricing (2)
Duchenne muscular dystrophy (4)
Earnings (14266)
Editorial (1)
Events (2234)
Executive appointments (5)
FDA (657)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (28)
Gene editing (9)
Generative AI (1)
Gene therapy (10)
GLP-1 (38)
Government (83)
Guidances (144)
Healthcare (683)
HIV (2)
IgA nephropathy (9)
Immunology and inflammation (8)
Immuno-oncology (1)
Indications (2)
Infectious disease (83)
Inflammatory bowel disease (3)
Inflation Reduction Act (1)
Intellectual property (6)
Interviews (9)
IPO (1469)
IRA (1)
Job creations (89)
Job search strategy (56)
JPM (1)
Layoffs (9)
Legal (159)
Lung cancer (39)
Lymphoma (20)
Machine learning (1)
Manufacturing (10)
MASH (10)
Medical device (672)
Medtech (678)
Mergers & acquisitions (493)
Metabolic disorders (50)
Multiple sclerosis (19)
NASH (2)
Neurodegenerative disease (9)
Neuropsychiatric disorders (5)
Neuroscience (116)
NextGen: Class of 2026 (142)
Non-profit (47)
Obesity (16)
Opinion (2)
Ovarian cancer (1)
Pain (4)
Pancreatic cancer (5)
Parkinson's disease (13)
Partnered (1)
Patents (8)
Patient recruitment (16)
Peanut (5)
People (848)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase 1 (725)
Phase 2 (1207)
Phase 3 (1087)
Pipeline (629)
Policy (3)
Postmarket research (231)
Preclinical (315)
Press Release (2)
Prostate cancer (3)
Radiopharmaceuticals (12)
Rare diseases (21)
Real estate (140)
Regulatory (675)
Reports (1)
Research institute (41)
Resumes & cover letters (3)
Rett syndrome (1)
RSV (6)
Schizophrenia (8)
Series A (2)
Series B (2)
Sickle cell disease (2)
Special edition (1)
Spinal muscular atrophy (3)
Startups (73)
Supply chain (1)
Vaccines (17)
Venture capital (3)
Weight loss (12)
Women's health (4)
Date
Last 7 days (23)
Last 30 days (62)
Last 365 days (1637)
2026 (72)
2025 (1649)
2024 (1781)
2023 (2048)
2022 (2349)
2021 (2412)
2020 (2165)
2019 (1355)
2018 (1059)
2017 (846)
2016 (582)
2015 (836)
2014 (509)
2013 (301)
2012 (382)
2011 (474)
2010 (564)
Location
Africa (22)
Alabama (4)
Arizona (16)
Asia (1814)
Australia (222)
California (524)
Canada (148)
China (52)
Colorado (33)
Connecticut (30)
Delaware (20)
Europe (3635)
Florida (90)
Georgia (18)
Idaho (1)
Illinois (42)
India (2)
Indiana (37)
Iowa (1)
Japan (21)
Kansas (2)
Kentucky (3)
Louisiana (5)
Maine (2)
Maryland (68)
Massachusetts (365)
Michigan (24)
Minnesota (40)
Mississippi (1)
Missouri (10)
Montana (2)
Nevada (3)
New Hampshire (9)
New Jersey (201)
New York (161)
North Carolina (88)
Northern California (283)
Ohio (10)
Pennsylvania (143)
South America (34)
Southern California (211)
Tennessee (5)
Texas (66)
United States (2067)
Utah (28)
Virginia (5)
Washington D.C. (3)
Washington State (41)
Wisconsin (7)
Wyoming (1)
29,366 Results for "107".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology
January 8, 2026
·
3 min read
Press Releases
Kivu Bioscience Announces First Patient Dosed in Phase 1 Trial of KIVU-107 Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors
January 12, 2026
·
1 min read
Press Releases
U.S. Pharmaceutical Market Size to Set to Reach USD 1,107.4 Billion by 2034
November 19, 2025
·
1 min read
Press Releases
Aclipse Therapeutics to Collaborate with Mayo Clinic on Phase 2 Clinical Development of M107 for the Treatment of Gastroparesis
November 18, 2025
·
2 min read
Press Releases
CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe
September 23, 2025
·
9 min read
Press Releases
Kivu Bioscience Presents Preclinical Data for KIVU-107 Demonstrating Potent and Durable Anti-Tumor Activity and a Wide Therapeutic Index at World ADC San Diego 2025
October 21, 2025
·
3 min read
Press Releases
Integra Therapeutics secures €10.7 million investment round to advance development of FiCAT gene writing platform and preclinical validation of CAR-T therapies
September 10, 2025
·
1 min read
Press Releases
Excision BioTherapeutics Announces Positive Preclinical Data Highlighting the Safety, Potency and Development Progress of the Hepatitis B EBT-107 Program at the ICE-HBV “Hepatitis B Cure Symposium”
September 16, 2025
·
3 min read
Press Releases
Viatris Announces Five Data Presentations on Novel Fast-Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Conference
August 1, 2025
·
5 min read
Press Releases
RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION
November 11, 2025
·
23 min read
1 of 2,937
Next
